Pharmaceutical Industries Air Quality

E. Oddone, S. Negri, F. Morandi, M. Imbriani

Research output: Contribution to journalArticle

Abstract

Active pharmaceutical ingredients (APIs) could be risk factors for workers exposed in pharmaceutical industries. Indeed, APIs are compounds specifically designed to interact with human organism and to modify its functioning, and some of them could act as carcinogens or sensitisers, for whom a safe threshold cannot be easily determined. Inhalation is the most important route of exposure.Occupational exposure limits are needed to protect workers' health, both concerning APIs and pharmaceutical intermediates. To date, several approaches have been suggested to set acceptable daily exposure limits in pharmaceutical industries, and they are a key point especially for carcinogens, sensitisers or endocrine disruptors.Despite literature evidence is sparse, occupational risks in pharmaceutical industries cannot be disregarded; several adverse health effects have been observed.In recent years, the quality of air in pharmaceutical industries has improved, even though a special attention has to be paid to exposures to carcinogens and sensitisers.

Original languageEnglish
JournalComprehensive Analytical Chemistry
DOIs
Publication statusAccepted/In press - 2016

Fingerprint

Air quality
Pharmaceutical Preparations
Industry
Carcinogens
Occupational risks
Health
Endocrine Disruptors
Air

Keywords

  • Air quality
  • Environmental monitoring
  • Occupational exposures
  • Pharmaceutical industry
  • Risk assessment

ASJC Scopus subject areas

  • Analytical Chemistry
  • Spectroscopy

Cite this

Pharmaceutical Industries Air Quality. / Oddone, E.; Negri, S.; Morandi, F.; Imbriani, M.

In: Comprehensive Analytical Chemistry, 2016.

Research output: Contribution to journalArticle

@article{010fc16d225743f79c5cc89b13c49a3d,
title = "Pharmaceutical Industries Air Quality",
abstract = "Active pharmaceutical ingredients (APIs) could be risk factors for workers exposed in pharmaceutical industries. Indeed, APIs are compounds specifically designed to interact with human organism and to modify its functioning, and some of them could act as carcinogens or sensitisers, for whom a safe threshold cannot be easily determined. Inhalation is the most important route of exposure.Occupational exposure limits are needed to protect workers' health, both concerning APIs and pharmaceutical intermediates. To date, several approaches have been suggested to set acceptable daily exposure limits in pharmaceutical industries, and they are a key point especially for carcinogens, sensitisers or endocrine disruptors.Despite literature evidence is sparse, occupational risks in pharmaceutical industries cannot be disregarded; several adverse health effects have been observed.In recent years, the quality of air in pharmaceutical industries has improved, even though a special attention has to be paid to exposures to carcinogens and sensitisers.",
keywords = "Air quality, Environmental monitoring, Occupational exposures, Pharmaceutical industry, Risk assessment",
author = "E. Oddone and S. Negri and F. Morandi and M. Imbriani",
year = "2016",
doi = "10.1016/bs.coac.2016.02.014",
language = "English",
journal = "Comprehensive Analytical Chemistry",
issn = "0166-526X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Pharmaceutical Industries Air Quality

AU - Oddone, E.

AU - Negri, S.

AU - Morandi, F.

AU - Imbriani, M.

PY - 2016

Y1 - 2016

N2 - Active pharmaceutical ingredients (APIs) could be risk factors for workers exposed in pharmaceutical industries. Indeed, APIs are compounds specifically designed to interact with human organism and to modify its functioning, and some of them could act as carcinogens or sensitisers, for whom a safe threshold cannot be easily determined. Inhalation is the most important route of exposure.Occupational exposure limits are needed to protect workers' health, both concerning APIs and pharmaceutical intermediates. To date, several approaches have been suggested to set acceptable daily exposure limits in pharmaceutical industries, and they are a key point especially for carcinogens, sensitisers or endocrine disruptors.Despite literature evidence is sparse, occupational risks in pharmaceutical industries cannot be disregarded; several adverse health effects have been observed.In recent years, the quality of air in pharmaceutical industries has improved, even though a special attention has to be paid to exposures to carcinogens and sensitisers.

AB - Active pharmaceutical ingredients (APIs) could be risk factors for workers exposed in pharmaceutical industries. Indeed, APIs are compounds specifically designed to interact with human organism and to modify its functioning, and some of them could act as carcinogens or sensitisers, for whom a safe threshold cannot be easily determined. Inhalation is the most important route of exposure.Occupational exposure limits are needed to protect workers' health, both concerning APIs and pharmaceutical intermediates. To date, several approaches have been suggested to set acceptable daily exposure limits in pharmaceutical industries, and they are a key point especially for carcinogens, sensitisers or endocrine disruptors.Despite literature evidence is sparse, occupational risks in pharmaceutical industries cannot be disregarded; several adverse health effects have been observed.In recent years, the quality of air in pharmaceutical industries has improved, even though a special attention has to be paid to exposures to carcinogens and sensitisers.

KW - Air quality

KW - Environmental monitoring

KW - Occupational exposures

KW - Pharmaceutical industry

KW - Risk assessment

UR - http://www.scopus.com/inward/record.url?scp=84969531708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969531708&partnerID=8YFLogxK

U2 - 10.1016/bs.coac.2016.02.014

DO - 10.1016/bs.coac.2016.02.014

M3 - Article

AN - SCOPUS:84969531708

JO - Comprehensive Analytical Chemistry

JF - Comprehensive Analytical Chemistry

SN - 0166-526X

ER -